These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1684 related articles for article (PubMed ID: 23866178)

  • 101. Long-term outcomes of elective drug-eluting stenting of the unprotected left main coronary artery in patients with normal left ventricular function.
    Lee MS; Yang T; Biondi-Zoccai G; Sillano D; Cerrato E; Tarantini G; Xhaxho J; Aragon J; Sheiban I
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):945-51. PubMed ID: 20824773
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.
    Tada T; Byrne RA; Simunovic I; King LA; Cassese S; Joner M; Fusaro M; Schneider S; Schulz S; Ibrahim T; Ott I; Massberg S; Laugwitz KL; Kastrati A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1267-74. PubMed ID: 24355117
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Long-term outcome of provisional side-branch T-stenting for the treatment of unprotected distal left main coronary artery disease.
    De Luca L; Altamura L; Corvo P; De Persio G; Ghini AS; Petrolini A; Aurigemma C; Tomai F
    Catheter Cardiovasc Interv; 2011 May; 77(6):765-72. PubMed ID: 21413124
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
    Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
    Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
    [TBL] [Abstract][Full Text] [Related]  

  • 105. The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease.
    Chieffo A; Tanaka A; Giustino G; Briede I; Sawaya FJ; Daemen J; Kawamoto H; Meliga E; D'Ascenzo F; Cerrato E; Stefanini GG; Capodanno D; Mangiameli A; Templin C; Erglis A; Morice MC; Mehran R; Van Mieghem NM; Nakamura S; De Benedictis M; Pavani M; Varbella F; Pisaniello M; Sharma SK; Tamburino C; Tchetche D; Colombo A;
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2401-2410. PubMed ID: 29217002
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Drug-eluting stents in patients on chronic hemodialysis: paclitaxel-eluting stents vs. limus-eluting stents.
    Sardi GL; Loh JP; Torguson R; Laynez-Carnicero A; Kitabata H; Xue Z; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2014 Mar; 15(2):86-91. PubMed ID: 24684759
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Stent thrombosis in early-generation drug-eluting stents versus newer-generation everolimus-eluting stent assorted by LVEF.
    van Boven N; Windecker S; Umans VA; van Domburg RT; Kardys I; Akkerhuis KM; van Geuns RJ; Serruys PW; Magro M; Räber L; Boersma E
    Heart; 2015 Jan; 101(1):50-7. PubMed ID: 25163692
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Outcome of percutaneous coronary intervention with drug-eluting stents in unprotected left main versus non-left main native coronary artery disease: results from the prospective multicenter German DES.DE registry.
    Akin I; Naber C; Sabin G; Hochadel M; Senges J; Kuck KH; Nienaber C; Richardt G; Tölg R
    Clin Res Cardiol; 2013 Sep; 102(9):679-86. PubMed ID: 23681360
    [TBL] [Abstract][Full Text] [Related]  

  • 110. 1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry.
    Woudstra P; Kalkman DN; den Heijer P; Menown IB; Erglis A; Suryapranata H; Arkenbout KE; Iñiguez A; van 't Hof AW; Muller P; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2016 Jun; 9(11):1127-34. PubMed ID: 27209254
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting.
    Chacko R; Mulhearn M; Novack V; Novack L; Mauri L; Cohen SA; Moses J; Leon MB; Cutlip DE
    JACC Cardiovasc Interv; 2009 Jun; 2(6):498-503. PubMed ID: 19539252
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Impact of multiple and long sirolimus-eluting stent implantation on 3-year clinical outcomes in the j-Cypher Registry.
    Shirai S; Kimura T; Nobuyoshi M; Morimoto T; Ando K; Soga Y; Yamaji K; Kondo K; Sakai K; Arita T; Goya M; Iwabuchi M; Yokoi H; Nosaka H; Mitsudo K;
    JACC Cardiovasc Interv; 2010 Feb; 3(2):180-8. PubMed ID: 20170875
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Long-term clinical outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease.
    Higami H; Shiomi H; Niki S; Tazaki J; Imai M; Saito N; Makiyama T; Shizuta S; Shioi T; Ono K; Kimura T
    Cardiovasc Interv Ther; 2015 Jul; 30(3):189-97. PubMed ID: 25194953
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Long-term comparison of everolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for percutaneous coronary intervention of saphenous vein grafts.
    Taniwaki M; Räber L; Magro M; Kalesan B; Onuma Y; Stefanini GG; van Domburg RT; Moschovitis A; Meier B; Jüni P; Serruys PW; Windecker S
    EuroIntervention; 2014; 9(12):1432-40. PubMed ID: 24064377
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Impact of interventional strategy for unprotected left main coronary artery percutaneous coronary intervention on long-term survival.
    Lehmann R; Ehrlich JR; De Rosa S; Spyridopoulos I; Laskowski R; Kremer J; Herrmann E; Zeiher AM; Schächinger V; Fichtlscherer S
    Can J Cardiol; 2012; 28(5):553-60. PubMed ID: 22554579
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Randomized Trial of Polymer-Free Sirolimus- and Probucol-Eluting Stents Versus Durable Polymer Zotarolimus-Eluting Stents: 5-Year Results of the ISAR-TEST-5 Trial.
    Kufner S; Sorges J; Mehilli J; Cassese S; Repp J; Wiebe J; Lohaus R; Lahmann A; Rheude T; Ibrahim T; Massberg S; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2016 Apr; 9(8):784-792. PubMed ID: 27017366
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Five-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital-(Research) Registry.
    Shen ZJ; García-García HM; Garg S; Onuma Y; Schenkeveld L; van Domburg RT; Serruys PW;
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):979-86. PubMed ID: 19753636
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Self-expandable sirolimus-eluting stents compared to second-generation drug-eluting stents for the treatment of the left main: A propensity score analysis from the SPARTA and the FAILS-2 registries.
    Montefusco A; D'Ascenzo F; Gili S; Smolka G; Chieffo A; Baumbach A; Escaned J; Sganzerla P; Tomassini F; Secco GG; Ugo F; Tamburino C; Nicolino A; Mancone M; Poli A; Yew KL; Cirillo P; Wanha W; Pastormerlo LE; di Summa R; Sardella G; Colombo A; Gaita F; Cortese B
    Catheter Cardiovasc Interv; 2019 Feb; 93(2):208-215. PubMed ID: 30298593
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Everolimus- versus sirolimus-eluting stents for the treatment of unprotected left main coronary artery stenosis (results from the EXCELLENT registry).
    Park KW; Lim WH; Ahn HS; Kang SH; Han JK; Lee SE; Cho JH; Gwon HC; Lee SY; Rhew JY; Kim W; Chae IH; Kim HS
    Int J Cardiol; 2013 Oct; 168(3):2738-44. PubMed ID: 23623141
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Long-term outcomes following mini-crush versus culotte stenting for the treatment of unprotected left main disease: Insights from the milan and New-Tokyo (MITO) registry.
    Kawamoto H; Takagi K; Chieffo A; Ruparelia N; Yusuke Fujino ; Yabushita H; Watanabe Y; Latib A; Carlino M; Montorfano M; Nakamura S; Colombo A
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):13-24. PubMed ID: 27471180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 85.